Document Type : Original Article(s)
                            
                        
                                                    Authors
                            
                                                            
                                                                            1
                                                                        Assistant Professor, Department of Psychiatry, School of Medicine, Yazd University of Medical Sciences, Yazd                                
                                                            
                                                                            2
                                                                        Assistant Professor, Department of Psychiatry, School of Medicine, Isfahan University of Medical Sciences, Isfahan                                
                                                            
                                                                            3
                                                                        General Practitioner, School of Medicine, Isfahan University of Medical Sciences, Isfahan                                
                            
                                                
                        
                            Abstract
                            Background:   The effects of bupropion in   control and treatment of Attention Deficit Hyperactivity Disorder (ADHD)   patients is not cleared yet. The aim of this study was to check its effects   on control of ADHD signs and symptoms.             Methods:In a Randomized, double blind,   placebo control clinical trial (which take 4 weeks), 40 ADHD children were   divided into two groups. The control group received bupropion but the placebo   group received placebo. Both of them took part in social skills sessions.   Conner's questionnaires (teacher's and parent's) were filled before, two   weeks, and 4 weeks of study. The social behavior questionnaires were filled   before and after the study. The Psychiatrist followed the patients and   evaluated the severity of the disease before, 2 weeks, and 4 weeks of the   study.             Findings:There were not any significant   difference between the scores of Conner’s   questionnaire (P = 0.77, P = 0.97, P = 0.95) and social skills questionnaire (P = 0.16, P = 0.29, P = 0.47).   Impulsivity (P = 0.41, P = 0.28),   accepted social behavior (P = 0.87,    P = 0.24), peer relationship (P = 0.28, P = 0.78), and communication skills (P   = 0.61, P =0.91) at any time of the study. The only difference was between   ADHD subscale of Conner’s questionnaire for teachers in the week 4 (P = 0.048).   There were not any statistical differences between the scores of severity   before and week 2 (P = 0.81, P = 0.79). But at the week 4 the severity score   was 0.6 greater in placebo than in control group (P = 0.044). the side   effects of the bupropion were nausea and vomiting in 3 patients, headache,   irritability, rash, anorexia, tick, confusion, agitation in 2 patients, and   tremor and night mare in one patient.             Conclusion: Finally despite partially   effects of bupropion on controlling the signs and symptoms of ADHD, more   expanded trials are suggested.                 Key words: Bupropion, Attention deficit hyperactive disorder (ADHD),   Conner’s questionnaire.